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The purpose of this study was to investigate the deoxycholic acid (DCA) reduction by 
Bifidobacterium pseudocatenulatum G4 at in vitro conditions with the emphasis of its 
bile salt deconjugation ability and antagonistic activity against 7α-dehydroxylating 
bacteria. B. pseudocatenulatum G4 showed antagonistic activity against Clostridium 
scindens and C. hiranonis at colonic pH (5.7, 6.2 and 6.8), with highest activity (4mm 
inhibition zone) at pH 5.7 against C. hiranonis. Growth rates of B. pseudocatenulatum 
G4 (time required for the initial absorbance at zero time to increase by 0.3 units), 
decreased in the presence of 2.0% oxgall compared to absence of oxgall. Effect of B. 
pseudocatenulatum G4 on pH reduction was measured; B. pseudocatenulatum G4 
reduced pH from 6.8 to 3.9 in TPY broth supplemented with 0.1% and pH 3.74 in TPY 
broth without oxgall (control), compared to pH 5.28 in TPY broth supplemented with 
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2.0% oxgall. This results showed oxgall exert inhibitory effect on pH reduction by B. 
pseudocatenulatum G4. 
 
Bile salt hydrolase (BSH) activity, which is the measurement of enzyme activity 
responsible for bile salt deconjugation, was quantified by high pressure liquid 
chromatography (HPLC) assay.  B. pseudocatenulatum G4 gave deconjugation rate 
(disappearance of conjugated bile acid) in TPY broth supplemented with 0.25 mM (the 
highest concentration in colon) and 5.0 mM (the highest concentration in small intestine) 
of all 6 different conjugated bile acids (TCA, GCA, TCDCA, GCDCA, TDCA, and 
GDCA). Generally B. pseudocatenulatum G4 deconjugated glycoconjugated bile acids in 
higher amount compare to tauroconjugates. The percentage of deconjugation activity was 
higher in TPY medium supplemented with 0.25mM bile acids compared to TPY broth 
with 5.0mM bile acids.  On other hand, pH 6.2 was observed as the optimum pH for BSH 
activity. Full factorial statistical design was used to evaluate the effects of three factors 
(pH, B. pseudocatenulatum G4 concentrations and Clostridiums) with different levels 
and interactions between them, on DCA production. Statistical analysis for results of the 
in vitro experiment showed that total DCA concentration produced by C. scindens and C. 
hiranonis in the presence of B. pseudocatenulatum G4 and low pH, were lower than the 
control group with highest pH and in the absence of B. pseudocatenulatum G4. 
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Oleh 
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Pengerusi : Profesor Mohd Yazid Abdul Manap, PhD 
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Tujuan kajian ini adalah untuk menyiasat penurunan asid deoksikolik (DCA) oleh 
Bifidobacterium pseudocatenulatum G4 pada keadaan in-vitro dengan penekanan 
terhadap kebolehan mengdekonjugat garam hempedu dan aktiviti antagonistiknya 
terhadap bakteria 7α-dehidroksilasi. B. pseudocatenulatum G4 menunjukkan aktiviti 
antagonistik terhadap Clostridium scindens dan C. hiranonis pada pH kolon (5.7, 6.2 dan 
6.8), dengan aktiviti tertinggi (zon perencatan 4mm) pada pH 5.7 terhadap  C. hiranonis. 
Kadar pertumbuhan B. pseudocatenulatum G4 (masa yang diperlukan untuk penyerapan 
awal pada masa kosong untuk meningkat sebanyak 0.3 unit), menurun dengan kehadiran 
2.0% oxgall berbanding dengan ketidakhadiran oxgall.  B. pseudocatenulatum G4 
menurunkan pH daripada 6.8 kepada 3.9 dalam broth TPY  yang ditambahkan 0.1% 
oxgall dan 3.74 dalam broth TPY tanpa oxgall (kawalan). Berbanding dengan pH 5.28 
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dalam broth TPY yang ditambahkan 2.0% oxgall,  keputusan ini menunjukkan oxgall 
mengeluarkan efek perencatan terhadap penurunan pH oleh B. pseudocatenulatum G4.  
 
Aktiviti hidrolase garam hempedu, yang mana pengukuran aktiviti enzim adalah 
bertanggungjawab kepada dekonjugasi garam hempedu, dikuantitikan dengan asai 
kromatografi cecair tekanan tinggi (HPLC). B. pseudocatenulatum G4 adalah isolat 
dengan kadar dekonjugasi (asid hempedu konjugat menghilang) yang tinggi  dalam broth 
TPY yang ditambahkan dengan 0.25 mM (kepekatan tertinggi dalam kolon) dan 5.0 mM 
(kepekatan tertinggi dalam usus kecil) semua jenis asid hempedu. Secara umum, strain 
ini mengdekonjugasikan asid-asid hempedu glikokonjugat dalam kuantiti yang lebih 
tinggi berbanding taurokonjugat. Begitu juga dalam peratusan keseluruhan aktiviti 
dekonjugasi adalah lebih tinggi dalam medium TPY yang ditambahkan dengan 0.25mM 
asid hempedu berbanding dengan broth TPY dengan 5.0mM asid hempedu. Sementara 
itu, pH 6.2 diperhatikan sebagai pH optimum untuk aktiviti BSH. Rekabentuk statistic 
factorial penuh telah digunkan untuk menilai kesan factor-faktor (pH, kepekatan B. 
pseudocatenulatum G4 dan Clostridiums) dengan peringkat yang berbeza dan hubungan 
di antara mereka, atas penghasilan DCA. Keputusan eksperimen ini menunjukkan 
bahawa jumlah kepekatan DCA yang dihasilkan oleh C. scindens dan C. hiranonis dalam 
kehadiran B. pseudocatenulatum G4  pada pH rendah adalah lebih rendah daripada 
kumpulan kawalan pada pH tinggi dengan ketidakhadiran B. pseudocatenulatum G4. 
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CHAPTER 1 
INTRODUCTION 
 
Bile acids are saturated, hydroxylated C-24 cyclopentanephenanthrene sterols 
synthesized from cholesterol in hepatocytes. The two primary bile acids synthesized in 
the human liver are cholic acid (CA; 3α, 7α, 12α-trihydroxy-5bcholan-24-oic acid) and 
chenodeoxycholic acid (CDCA; 3α, 7α-dihydroxy-5b-cholan-24-oic acid). Bile acids are 
further metabolized by the liver via conjugation (N-acyl amidation) to glycine or 
taurine. Thus, at physiological pH, conjugated bile acids are almost fully ionized and 
may be termed bile salts (McGarr et al., 2005). Bile salts are secreted actively across the 
canalicular membrane and are carried in bile to the gallbladder, where they are 
concentrated during the inter-digestive period. After a meal, the release of 
cholecystokinin from the duodenum stimulates the gallbladder to contract, causing bile 
to flow into the duodenum.  
 
Bile salts are highly effective detergents that promote solubilization, digestion, and 
absorption of dietary lipids and lipid-soluble vitamins throughout the small intestine. 
High concentrations of bile salts are maintained in the duodenum, jejunum, and 
proximal ileum, where fat digestion and absorption take place. Bile salts are then 
absorbed through high-affinity active transport in the distal ileum (Vlahcevic et al., 
1996). Upon entering the bloodstream, bile salts are complexes to plasma proteins and 
returned to the liver. Upon reaching the liver, they are cleared efficiently from the 
circulation by active transporters on the sinusoidal membrane of hepatocytes and rapidly 
secreted into bile. This process is known as the enterohepatic circulation (Ridlon et al., 
2006). 
 
However, roughly 5% (approximately 400–800 mg) of the bile acid pool escapes ileal 
absorption and enters the large intestines each day and becomes substrate for significant 
microbial biotransforming reactions in the large bowel (Doerner et al., 1997). The 
secondary bile acids deoxycholic acid (DCA; 3α, 12α-dihydroxy- 5b-cholan-24-oic 
acid) and lithocholic acid (LCA; 3α-hydroxy-5b-cholan-24-oic acid) are produced solely 
by microbial biotransforming reactions (7α-dehydroxylation by colonic bacteria) in the 
human large intestine. Of the three hydroxyl groups (3α, 7α and 12α) of naturally 
occurring bile acids, the 7α-hydroxyl-group is the most readily degraded by human 
intestinal flora (Macdonald et al., 1982). 7α-dehydroxylation is the most quantitatively 
important bacterial bile salt biotransformation in the human colon. Unlike rodents, the 
human liver cannot 7α-hydroxylate DCA, forming CA. Hence, under normal 
physiological conditions, there is no metabolic pathway for removing DCA from the 
bile acid pool in humans. The amount of DCA in the bile acid pool is a function of at 
least three variables: 1) the rate of formation and absorption of DCA through the colon 
(input); 2) colonic transit time; and 3) colonic pH.  High levels of DCA in blood, bile, 
and feces have been correlated with an increased risk of cholesterol gallstone disease 
and colon cancer (Ridlon et al., 2006). 
 
Current research however, has demonstrated the important role that the normal 
gastrointestinal microflora plays in animal health and nutrition, as well as highlighting 
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the ecological significance of intestinal pathogens. Members of the genera Clostridium 
(C. scindens, C. hiranonis) and Eubacterium are the predominant intestinal species 
exhibiting bile acid 7α-dehydroxylating activity. Eubacterium sp. strain VPI 12708 has 
been shown to have a multistep bile acid 7α-dehydroxylation pathway with most of the 
required enzymes (Doerner et al., 1997). High levels of CA 7α-dehydroxylating fecal 
bacteria have been correlated with increased amounts of DCA in bile of a subset of 
cholesterol gallstone patients. Secondary bile acids, may contribute to the pathogenesis 
of colon cancer, gallstones, and other gastrointestinal (GI) diseases (Ridlon et al., 2006). 
However, base on speculation, the ways to preventing the occurrence of these 
mechanisms are: 1) eliminating primary bile acids in colon (input); 2) decrease in the 
number of bile acid 7α-dehydroxylating bacteria; and 3) eliminating deoxycholic acid 
(secondary bile acid; output). 
 
As conjugated bile salts possess antimicrobial activity, bacteria seem to have evolved to 
produce bile salt hydrolase (BSH) to neutralize this adverse activity. A number of 
bacterial strains possessing deconjugating activity such as anaerobic Lactobacillaceae 
and Bifidobacteria have been isolated and these have been shown to be present in ileal 
and fecal content (Yazid et al., 1999; Mariam et al., 2004; Suresh Kumar et al., 2006). 
 
Bifidobacteria are natural members of the human intestinal microbiota, in which they 
occur at concentrations of 109 to 1011 cfu/ g of feces, and represent up to 91% of the 
total gut population during the early stages of life. The mechanisms allowing intestinal 
bacteria to resist physiological bile salts concentrations remain poorly understood and 
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